HC Andersen Capital Events 01/02: Meet the top management in Zerion Pharma

Report this content

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.

Zerion Pharma – Company Introduction

Meet Zerion Pharma’s management team, CEO Ole Wiborg and CFO Jakob Dynnes Hansen, when they introduce the company in relation to a private placement. Zerion Pharma is a non-listed Danish company. 

ZERION Pharma is a pharmaceutical company specialized in improving the bioavailability of oral drugs by increasing their solubility. The company was established in 2019 as a spinout from the University of Copenhagen and today has 15 employees and its own laboratories. ZERION has established collaborations with several of the largest pharmaceutical companies in the world, and in addition develops its own drug formulations as improvements to existing marketed drugs. ZERION plans to start human clinical studies for its first proprietary product, an anti-cancer drug, during 2023.  

ZERION has developed the Dispersome® platform technology that improves the solubility of poorly soluble oral drugs and improves bioavailability and therapeutic options for patients. The Dispersome® technology is based on the production of stable amorphous formulations by mixing high amounts of drug substance with beta-lactoglobulin supplied by Arla Food Ingredients. The Dispersome® technology is patent protected.  

Disclaimer: HC Andersen Capital receives payment from Zerion Pharma for a Digital IR/Corporate Visibility agreement. Zerion Pharma is a private company (i.e. not listed on a regulated stock market). Investors should therefore be aware of the potential risks that can be associated with investing in a private company, including liquidity conditions, how shares are traded as well as the process of the specific capital raise. /Claus Thestrup kl. 11.27 27-01-2023

Sign up via. Link

Wednesday 1st of February 11:00 - 11:30
 

Disclaimer: HC Andersen Capital receives payment from the companies mentioned for a DigitalIR/Corporate Visibility agreement. The content is not buy or sell recommendations. 

Mie Halse
Head of Digital and Events
mie@hcandersencapital.dk
+45 28746640
 

HC Andersen Capital digitizes the relationship between listed companies and investors. We work long-term for companies that want more visibility in the market. #DemocraticIR - HC Andersen Capital works to democratize access to the financial market.

Subscribe